Shares of Arno Therapeutics, Inc. (OTCMKTS:ARNI – Get Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.00 and traded as high as $0.00. Arno Therapeutics shares last traded at $0.00, with a volume of 0 shares traded.
Arno Therapeutics Trading Down 100.0 %
Arno Therapeutics Company Profile
Arno Therapeutics, Inc, a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company’s product development pipeline includes Onapristone, a type 1 anti-progestin hormone blocker that is in Phase I/II clinical study for the treatment of breast, endometrial, and others solid tumors in post-menopausal women; and advanced castration-resistant prostate cancer in men.
Read More
- Five stocks we like better than Arno Therapeutics
- Insider Buying Explained: What Investors Need to Know
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- Golden Cross Stocks: Pattern, Examples and Charts
- Nebius Group: The Rising Star in AI Infrastructure
- Election Stocks: How Elections Affect the Stock Market
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for Arno Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arno Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
